Governmental Vision

Governmental Vision Biotechnology is the engine that will make North Rhine-Westphalia Germany's most innovative state. Opinion By Minister President Jürgen Rüttgers As Federal Research Minister, I introduced Germany as a potential biotechnology location at the BIO fair in New York in 1998. I had every reason to be pleased with the enthusiasm of the American media. "Germany is back!" they wrote. Back home, I was awarded the title "Entrepre

Written byJurgen Ruttgers
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

As Federal Research Minister, I introduced Germany as a potential biotechnology location at the BIO fair in New York in 1998. I had every reason to be pleased with the enthusiasm of the American media. "Germany is back!" they wrote. Back home, I was awarded the title "Entrepreneur of the Year," a distinction that made me particularly proud. After all, it is not the kind of award a politician receives often. And now, as minister-president of North Rhine-Westphalia, I can say that biotechnology is still one of my major concerns.

BIO.NRW

Unchaining a champion

From Coal to CLIB

Advancing Research

It's all about Cells

Andreas Pinkwart

Tap the Full Potential

Bayer

Detlev Riesner

Cooling the German Discussion

Dasgip

Homeward Bound

The region intersected by the rivers Rhine and Ruhr is one of the most vigorous and important economic areas in the world. This was the case during the first industrial ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies